<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Paramedic Medication Field Guide</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    
    <!-- Embedded Tailwind CSS -->
    <style>
        /*
        ! tailwindcss v3.4.1 | MIT License | https://tailwindcss.com
        */
        *,::before,::after{box-sizing:border-box;border-width:0;border-style:solid;border-color:#e5e7eb}::before,::after{--tw-content:''}html{line-height:1.5;-webkit-text-size-adjust:100%;-moz-tab-size:4;tab-size:4;font-family:ui-sans-serif,system-ui,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol","Noto Color Emoji";font-feature-settings:normal;font-variation-settings:normal;-webkit-tap-highlight-color:transparent}body{margin:0;line-height:inherit}hr{height:0;color:inherit;border-top-width:1px}abbr:where([title]){-webkit-text-decoration:underline dotted;text-decoration:underline dotted}h1,h2,h3,h4,h5,h6{font-size:inherit;font-weight:inherit}a{color:inherit;text-decoration:inherit}b,strong{font-weight:bolder}code,kbd,samp,pre{font-family:ui-monospace,SFMono-Regular,Menlo,Monaco,Consolas,"Liberation Mono","Courier New",monospace;font-feature-settings:normal;font-variation-settings:normal;font-size:1em}small{font-size:80%}sub,sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sub{bottom:-.25em}sup{top:-.5em}table{text-indent:0;border-color:inherit;border-collapse:collapse}button,input,optgroup,select,textarea{font-family:inherit;font-feature-settings:inherit;font-variation-settings:inherit;font-size:100%;font-weight:inherit;line-height:inherit;color:inherit;margin:0;padding:0}button,select{text-transform:none}button,[type=button],[type=reset],[type=submit]{-webkit-appearance:button;background-color:transparent;background-image:none}:-moz-focusring{outline:auto}:-moz-ui-invalid{box-shadow:none}progress{vertical-align:baseline}::-webkit-inner-spin-button,::-webkit-outer-spin-button{height:auto}[type=search]{-webkit-appearance:textfield;outline-offset:-2px}::-webkit-search-decoration{-webkit-appearance:none}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}summary{display:list-item}blockquote,dl,dd,h1,h2,h3,h4,h5,h6,hr,figure,p,pre{margin:0}fieldset{margin:0;padding:0}legend{padding:0}ol,ul,menu{list-style:none;margin:0;padding:0}dialog{padding:0}textarea{resize:vertical}input::placeholder,textarea::placeholder{opacity:1;color:#9ca3af}button,[role=button]{cursor:pointer}:disabled{cursor:default}img,svg,video,canvas,audio,iframe,embed,object{display:block;vertical-align:middle}img,video{max-width:100%;height:auto}[hidden]{display:none}*, ::before, ::after{--tw-border-spacing-x:0;--tw-border-spacing-y:0;--tw-translate-x:0;--tw-translate-y:0;--tw-rotate:0;--tw-skew-x:0;--tw-skew-y:0;--tw-scale-x:1;--tw-scale-y:1;--tw-pan-x: ;--tw-pan-y: ;--tw-pinch-zoom: ;--tw-scroll-snap-strictness:proximity;--tw-gradient-from-position: ;--tw-gradient-via-position: ;--tw-gradient-to-position: ;--tw-ordinal: ;--tw-slashed-zero: ;--tw-numeric-figure: ;--tw-numeric-spacing: ;--tw-numeric-fraction: ;--tw-ring-inset: ;--tw-ring-offset-width:0px;--tw-ring-offset-color:#fff;--tw-ring-color:rgb(59 130 246 / .5);--tw-ring-offset-shadow:0 0 #0000;--tw-ring-shadow:0 0 #0000;--tw-shadow:0 0 #0000;--tw-shadow-colored:0 0 #0000;--tw-blur: ;--tw-brightness: ;--tw-contrast: ;--tw-grayscale: ;--tw-hue-rotate: ;--tw-invert: ;--tw-saturate: ;--tw-sepia: ;--tw-drop-shadow: ;--tw-backdrop-blur: ;--tw-backdrop-brightness: ;--tw-backdrop-contrast: ;--tw-backdrop-grayscale: ;--tw-backdrop-hue-rotate: ;--tw-backdrop-invert: ;--tw-backdrop-opacity: ;--tw-backdrop-saturate: ;--tw-backdrop-sepia: }::backdrop{--tw-border-spacing-x:0;--tw-border-spacing-y:0;--tw-translate-x:0;--tw-translate-y:0;--tw-rotate:0;--tw-skew-x:0;--tw-skew-y:0;--tw-scale-x:1;--tw-scale-y:1;--tw-pan-x: ;--tw-pan-y: ;--tw-pinch-zoom: ;--tw-scroll-snap-strictness:proximity;--tw-gradient-from-position: ;--tw-gradient-via-position: ;--tw-gradient-to-position: ;--tw-ordinal: ;--tw-slashed-zero: ;--tw-numeric-figure: ;--tw-numeric-spacing: ;--tw-numeric-fraction: ;--tw-ring-inset: ;--tw-ring-offset-width:0px;--tw-ring-offset-color:#fff;--tw-ring-color:rgb(59 130 246 / .5);--tw-ring-offset-shadow:0 0 #0000;--tw-ring-shadow:0 0 #0000;--tw-shadow:0 0 #0000;--tw-shadow-colored:0 0 #0000;--tw-blur: ;--tw-brightness: ;--tw-contrast: ;--tw-grayscale: ;--tw-hue-rotate: ;--tw-invert: ;--tw-saturate: ;--tw-sepia: ;--tw-drop-shadow: ;--tw-backdrop-blur: ;--tw-backdrop-brightness: ;--tw-backdrop-contrast: ;--tw-backdrop-grayscale: ;--tw-backdrop-hue-rotate: ;--tw-backdrop-invert: ;--tw-backdrop-opacity: ;--tw-backdrop-saturate: ;--tw-backdrop-sepia: }.container{width:100%}@media (min-width: 640px){.container{max-width:640px}}@media (min-width: 768px){.container{max-width:768px}}@media (min-width: 1024px){.container{max-width:1024px}}@media (min-width: 1280px){.container{max-width:1280px}}@media (min-width: 1536px){.container{max-width:1536px}}.visible{visibility:visible}.collapse{visibility:collapse}.absolute{position:absolute}.relative{position:relative}.sticky{position:sticky}.inset-y-0{top:0;bottom:0}.inset-0{top:0;right:0;bottom:0;left:0}.left-0{left:0}.left-4{left:1rem}.bottom-0{bottom:0}.right-0{right:0}.top-0{top:0}.z-50{z-index:50}.mx-auto{margin-left:auto;margin-right:auto}.my-8{margin-top:2rem;margin-bottom:2rem}.mt-1{margin-top:.25rem}.mt-12{margin-top:3rem}.mt-2{margin-top:.5rem}.mt-3{margin-top:.75rem}.mt-4{margin-top:1rem}.mt-5{margin-top:1.25rem}.mb-2{margin-bottom:.5rem}.block{display:block}.flex{display:flex}.table{display:table}.grid{display:grid}.hidden{display:none}.h-10{height:2.5rem}.h-12{height:3rem}.h-5{height:1.25rem}.h-6{height:1.5rem}.h-8{height:2rem}.w-10{width:2.5rem}.w-12{width:3rem}.w-5{width:1.25rem}.w-6{width:1.5rem}.w-8{width:2rem}.w-full{width:100%}.max-w-3xl{max-width:48rem}.max-w-5xl{max-width:64rem}.flex-shrink-0{flex-shrink:0}.cursor-pointer{cursor:pointer}.grid-cols-1{grid-template-columns:repeat(1,minmax(0,1fr))}.items-center{align-items:center}.items-start{align-items:start}.justify-center{justify-content:center}.justify-between{justify-content:space-between}.gap-4{gap:1rem}.gap-x-1\.5{gap-left:0.375rem;gap-right:0.375rem}.gap-y-1{gap-top:.25rem;gap-bottom:.25rem}.gap-y-6{gap-top:1.5rem;gap-bottom:1.5rem}.space-y-3>:not([hidden])~:not([hidden]){--tw-space-y-reverse:0;margin-top:calc(.75rem * calc(1 - var(--tw-space-y-reverse)));margin-bottom:calc(.75rem * var(--tw-space-y-reverse))}.space-y-4>:not([hidden])~:not([hidden]){--tw-space-y-reverse:0;margin-top:calc(1rem * calc(1 - var(--tw-space-y-reverse)));margin-bottom:calc(1rem * var(--tw-space-y-reverse))}.overflow-hidden{overflow:hidden}.rounded-lg{border-radius:.5rem}.rounded-xl{border-radius:.75rem}.rounded-full{border-radius:9999px}.rounded-md{border-radius:.375rem}.border-b{border-bottom-width:1px}.border-t{border-top-width:1px}.border-b-2{border-bottom-width:2px}.border-slate-200{--tw-border-opacity:1;border-color:rgb(226 232 240 / var(--tw-border-opacity))}.border-teal-200{--tw-border-opacity:1;border-color:rgb(153 246 228 / var(--tw-border-opacity))}.bg-white{--tw-bg-opacity:1;background-color:rgb(255 255 255 / var(--tw-bg-opacity))}.bg-slate-100{--tw-bg-opacity:1;background-color:rgb(241 245 249 / var(--tw-bg-opacity))}.bg-red-50{--tw-bg-opacity:1;background-color:rgb(254 242 242 / var(--tw-bg-opacity))}.bg-sky-50{--tw-bg-opacity:1;background-color:rgb(240 249 255 / var(--tw-bg-opacity))}.bg-teal-50{--tw-bg-opacity:1;background-color:rgb(240 253 250 / var(--tw-bg-opacity))}.bg-white\/70{background-color:rgb(255 255 255 / .7)}.p-4{padding:1rem}.p-5{padding:1.25rem}.px-4{padding-left:1rem;padding-right:1rem}.px-5{padding-left:1.25rem;padding-right:1.25rem}.py-2{padding-top:.5rem;padding-bottom:.5rem}.py-5{padding-top:1.25rem;padding-bottom:1.25rem}.py-8{padding-top:2rem;padding-bottom:2rem}.pl-11{padding-left:2.75rem}.pl-4{padding-left:1rem}.pr-4{padding-right:1rem}.pt-2{padding-top:.5rem}.pb-2{padding-bottom:.5rem}.py-3\.5{padding-top:.875rem;padding-bottom:.875rem}.px-2\.5{padding-left:.625rem;padding-right:.625rem}.py-1\.5{padding-top:.375rem;padding-bottom:.375rem}.text-center{text-align:center}.text-xs{font-size:.75rem;line-height:1rem}.text-lg{font-size:1.125rem;line-height:1.75rem}.text-sm{font-size:.875rem;line-height:1.25rem}.text-2xl{font-size:1.5rem;line-height:2rem}.font-bold{font-weight:700}.font-semibold{font-weight:600}.uppercase{text-transform:uppercase}.leading-relaxed{line-height:1.625}.tracking-tight{letter-spacing:-.025em}.tracking-wider{letter-spacing:.05em}.text-red-600{--tw-text-opacity:1;color:rgb(220 38 38 / var(--tw-text-opacity))}.text-red-700{--tw-text-opacity:1;color:rgb(185 28 28 / var(--tw-text-opacity))}.text-slate-400{--tw-text-opacity:1;color:rgb(148 163 184 / var(--tw-text-opacity))}.text-slate-500{--tw-text-opacity:1;color:rgb(100 116 139 / var(--tw-text-opacity))}.text-slate-600{--tw-text-opacity:1;color:rgb(71 85 105 / var(--tw-text-opacity))}.text-slate-700{--tw-text-opacity:1;color:rgb(51 65 85 / var(--tw-text-opacity))}.text-slate-800{--tw-text-opacity:1;color:rgb(30 41 59 / var(--tw-text-opacity))}.text-slate-900{--tw-text-opacity:1;color:rgb(15 23 42 / var(--tw-text-opacity))}.text-sky-600{--tw-text-opacity:1;color:rgb(2 132 199 / var(--tw-text-opacity))}.text-sky-700{--tw-text-opacity:1;color:rgb(3 105 161 / var(--tw-text-opacity))}.text-teal-500{--tw-text-opacity:1;color:rgb(20 184 166 / var(--tw-text-opacity))}.text-teal-600{--tw-text-opacity:1;color:rgb(13 148 136 / var(--tw-text-opacity))}.text-teal-700{--tw-text-opacity:1;color:rgb(15 118 110 / var(--tw-text-opacity))}.text-teal-800{--tw-text-opacity:1;color:rgb(17 94 89 / var(--tw-text-opacity))}.underline{text-decoration-line:underline}.placeholder\:text-slate-400::placeholder{--tw-placeholder-opacity:1;color:rgb(148 163 184 / var(--tw-placeholder-opacity))}.shadow-sm{--tw-shadow:0 1px 2px 0 rgb(0 0 0 / .05);--tw-shadow-colored:0 1px 2px 0 var(--tw-shadow-color);box-shadow:var(--tw-ring-offset-shadow, 0 0 #0000),var(--tw-ring-shadow, 0 0 #0000),var(--tw-shadow)}.shadow-lg{--tw-shadow:0 10px 15px -3px rgb(0 0 0 / .1), 0 4px 6px -4px rgb(0 0 0 / .1);--tw-shadow-colored:0 10px 15px -3px var(--tw-shadow-color), 0 4px 6px -4px var(--tw-shadow-color);box-shadow:var(--tw-ring-offset-shadow, 0 0 #0000),var(--tw-ring-shadow, 0 0 #0000),var(--tw-shadow)}.ring-1{--tw-ring-offset-shadow:var(--tw-ring-inset) 0 0 0 var(--tw-ring-offset-width) var(--tw-ring-offset-color);--tw-ring-shadow:var(--tw-ring-inset) 0 0 0 calc(1px + var(--tw-ring-offset-width)) var(--tw-ring-color);box-shadow:var(--tw-ring-offset-shadow, 0 0 #0000),var(--tw-ring-shadow, 0 0 #0000),var(--tw-shadow)}.ring-inset{--tw-ring-inset:inset}.ring-slate-300{--tw-ring-opacity:1;--tw-ring-color:rgb(203 213 225 / var(--tw-ring-opacity))}.transition-shadow{transition-property:box-shadow;transition-timing-function:cubic-bezier(.4,0,.2,1);transition-duration:.15s}.transition-colors{transition-property:color,background-color,border-color,text-decoration-color,fill,stroke;transition-timing-function:cubic-bezier(.4,0,.2,1);transition-duration:.15s}.duration-200{transition-duration:.2s}.duration-300{transition-duration:.3s}.hover\:shadow-lg:hover{--tw-shadow:0 10px 15px -3px rgb(0 0 0 / .1), 0 4px 6px -4px rgb(0 0 0 / .1);--tw-shadow-colored:0 10px 15px -3px var(--tw-shadow-color), 0 4px 6px -4px var(--tw-shadow-color);box-shadow:var(--tw-ring-offset-shadow, 0 0 #0000),var(--tw-ring-shadow, 0 0 #0000),var(--tw-shadow)}.hover\:bg-slate-50\/50:hover{background-color:rgb(248 250 252 / .5)}.hover\:bg-teal-100:hover{--tw-bg-opacity:1;background-color:rgb(204 251 241 / var(--tw-bg-opacity))}.hover\:text-teal-500:hover{--tw-text-opacity:1;color:rgb(20 184 166 / var(--tw-text-opacity))}.hover\:text-teal-800:hover{--tw-text-opacity:1;color:rgb(17 94 89 / var(--tw-text-opacity))}.focus\:ring-2:focus{--tw-ring-offset-shadow:var(--tw-ring-inset) 0 0 0 var(--tw-ring-offset-width) var(--tw-ring-offset-color);--tw-ring-shadow:var(--tw-ring-inset) 0 0 0 calc(2px + var(--tw-ring-offset-width)) var(--tw-ring-color);box-shadow:var(--tw-ring-offset-shadow, 0 0 #0000),var(--tw-ring-shadow, 0 0 #0000),var(--tw-shadow)}.focus\:ring-inset:focus{--tw-ring-inset:inset}.focus\:ring-teal-600:focus{--tw-ring-opacity:1;--tw-ring-color:rgb(13 148 136 / var(--tw-ring-opacity))}@media (min-width: 640px){.sm\:px-6{padding-left:1.5rem;padding-right:1.5rem}.sm\:text-sm{font-size:.875rem;line-height:1.25rem}.sm\:leading-6{line-height:1.5rem}.sm\:text-3xl{font-size:1.875rem;line-height:2.25rem}}@media (min-width: 1024px){.lg\:px-8{padding-left:2rem;padding-right:2rem}}
    </style>
    
    <!-- Custom Styles -->
    <style>
        body { background-color: #f8fafc; }
        .sticky-header {
            position: sticky; top: 0; z-index: 50;
            backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px);
            background-color: rgba(248, 250, 252, 0.85);
            border-bottom: 1px solid #e2e8f0;
        }
        .accordion-content {
            max-height: 0; overflow: hidden;
            transition: max-height 0.5s cubic-bezier(0.4, 0, 0.2, 1), padding 0.5s cubic-bezier(0.4, 0, 0.2, 1);
            padding-top: 0; padding-bottom: 0;
        }
        .accordion-content.open { max-height: 1500px; padding-top: 1rem; padding-bottom: 1.5rem; }
        .accordion-header svg { transition: transform 0.3s ease-in-out; }
        .accordion-header.open svg { transform: rotate(180deg); }
    </style>
</head>
<body class="text-slate-800">

    <!-- Main Container -->
    <div class="container mx-auto max-w-5xl">

        <!-- Header -->
        <header class="sticky-header">
            <div class="px-4 py-5 sm:px-6 lg:px-8">
                <div class="flex items-center gap-4">
                     <div class="flex-shrink-0">
                        <svg class="h-10 w-10 text-teal-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                          <path stroke-linecap="round" stroke-linejoin="round" d="M12 6.042A8.967 8.967 0 0 0 6 3.75c-1.052 0-2.062.18-3 .512v14.25A8.987 8.987 0 0 1 6 18c2.305 0 4.408.867 6 2.292m0-14.25a8.966 8.966 0 0 1 6-2.292c1.052 0 2.062.18 3 .512v14.25A8.987 8.987 0 0 0 18 18a8.967 8.967 0 0 0-6-2.292m0 0A9.043 9.043 0 0 1 12 6.042" />
                        </svg>
                    </div>
                    <div>
                        <h1 class="text-2xl sm:text-3xl font-bold text-slate-900 tracking-tight">Paramedic Field Guide</h1>
                        <p class="mt-1 text-sm text-slate-600">Rapid access medication reference for EMS professionals.</p>
                         <p class="mt-2 text-xs text-slate-500">
                            Source Protocols: 
                            <a href="https://collegeofparamedics.sk.ca/professional-practice/protocol-manuals/" target="_blank" rel="noopener noreferrer" class="font-medium text-teal-600 hover:text-teal-500 underline">
                                Saskatchewan College of Paramedics
                            </a>
                        </p>
                    </div>
                </div>
                
                <!-- Search Input -->
                <div class="mt-5 relative">
                    <div class="pointer-events-none absolute inset-y-0 left-0 flex items-center pl-4">
                        <svg class="h-5 w-5 text-slate-400" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 20 20" fill="currentColor" aria-hidden="true">
                            <path fill-rule="evenodd" d="M9 3.5a5.5 5.5 0 100 11 5.5 5.5 0 000-11zM2 9a7 7 0 1112.452 4.391l3.328 3.329a.75.75 0 11-1.06 1.06l-3.329-3.328A7 7 0 012 9z" clip-rule="evenodd" />
                        </svg>
                    </div>
                    <input type="text" id="searchInput" placeholder="Search by name, indication, etc..." class="block w-full rounded-lg border-0 bg-white py-3.5 pl-11 pr-4 text-slate-900 ring-1 ring-inset ring-slate-300 placeholder:text-slate-400 focus:ring-2 focus:ring-inset focus:ring-teal-600 sm:text-sm sm:leading-6">
                </div>
            </div>
        </header>

        <!-- A-Z Quick Navigation -->
        <nav class="bg-white/70 px-4 py-2 sm:px-6 lg:px-8 shadow-sm">
            <div id="az-nav" class="flex flex-wrap justify-center gap-x-1.5 gap-y-1 text-sm font-semibold">
                <!-- A-Z links will be generated here by JS -->
            </div>
        </nav>

        <!-- Medication List -->
        <main id="medicationList" class="p-4 sm:p-6 lg:p-8 space-y-4">
            <!-- Medication cards will be injected here -->
        </main>

        <!-- No Results Message -->
        <div id="noResults" class="hidden text-center py-16 px-6">
            <svg class="mx-auto h-12 w-12 text-slate-400" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor" aria-hidden="true">
              <path stroke-linecap="round" stroke-linejoin="round" d="m21 21-5.197-5.197m0 0A7.5 7.5 0 1 0 5.196 5.196a7.5 7.5 0 0 0 10.607 10.607Z" />
            </svg>
            <h3 class="mt-2 text-lg font-semibold text-slate-800">No Medications Found</h3>
            <p class="mt-1 text-sm text-slate-500">Your search did not match any medications. Please try again.</p>
        </div>

    </div>

    <!-- Footer with Disclaimer -->
    <footer class="bg-slate-100 border-t border-slate-200 mt-12">
        <div class="container mx-auto max-w-5xl py-8 px-4 sm:px-6 lg:px-8 text-center text-slate-500">
            <h4 class="font-semibold text-slate-700 mb-2">Legal Disclaimer</h4>
            <p class="text-xs max-w-3xl mx-auto">
                This guide is intended for rapid reference and educational purposes only. It is not a substitute for the official Saskatchewan College of Paramedics (SCoP) Clinical Practice Protocols, medical direction, or professional clinical judgment. The user assumes full responsibility for the accurate administration of any medication. Always refer to the most current official protocols and consult with medical control as required. The developers of this tool are not liable for any errors, omissions, or for any outcomes resulting from the use of this information.
            </p>
        </div>
    </footer>

    <!-- Embedded JavaScript -->
    <script>
        // --- DATA STORE ---
        const medications = [
            { 
                name: 'Acetaminophen', 
                indications: 'Severe sepsis/septic shock (adult), Pyrexic child/adult, Pain control', 
                contraindications: 'Hypersensitivity, Acetaminophen-induced liver disease', 
                dosing: {
                    'Adult': 'Oral: 1 g every 6 hours. Rectal: 325 to 650 mg every 4 to 6 hours.',
                    'Elderly (≥75 years)': 'Oral: 500-1000 mg every 6 hours.',
                    'Pediatric': 'Oral/Rectal: 10 to 15 mg/kg every 4 to 6 hours (max 75mg/kg/24h, or 4g/24h).'
                }, 
                route: 'EMR: PO; PCP/ICP/ACP: PO/PR.' 
            },
            { 
                name: 'Acetylsalicylic Acid (ASA)', 
                indications: 'Ischemic chest pain', 
                contraindications: 'Hypersensitivity to ASA/NSAIDs, active ulcer disease (relative)', 
                dosing: {
                    'Adult/Elderly - Ischemic Chest Pain': '160 mg, uncoated, chewed and swallowed.'
                }, 
                route: 'EMR/PCP/ICP/ACP: Chew and swallow.' 
            },
            { 
                name: 'Activated Charcoal', 
                indications: 'Treatment of most oral poisonings (except corrosives, iron, lithium, etc.)', 
                contraindications: 'Ingestion of corrosive agents, unprotected airway, GI tract not intact', 
                dosing: {
                    'Adult/Elderly - Oral Poisoning': '50 grams PO.',
                    'Pediatric - Oral Poisoning': 'Contact PADIS (1 g/kg).'
                }, 
                route: 'EMR/PCP/ICP/ACP: Oral.' 
            },
            { 
                name: 'Adenosine', 
                indications: 'Conversion of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm', 
                contraindications: '2nd or 3rd degree AV block, sick sinus syndrome, symptomatic bradycardia (unless pacemaker present)', 
                dosing: {
                    'Adult - PSVT': '1st dose: 6 mg IV over 1-2s w/ rapid 20mL flush. 2nd dose: 12 mg IV over 1-2s w/ rapid 20mL flush if needed.',
                    'Pediatric - PSVT': '1st dose: 0.1 mg/kg IV (max 6 mg). 2nd dose: 0.2 mg/kg IV (max 12 mg) if needed.',
                    'Special Populations': 'Reduce initial dose to 3mg for patients on carbamazepine/dipyridamole or with central line. Reduce to 1mg for heart transplant patients.'
                }, 
                route: 'ACP: IV, IO, CVL.' 
            },
            { 
                name: 'Amiodarone', 
                indications: 'Life-threatening recurring VFib and hemodynamically unstable VT', 
                contraindications: 'Hypersensitivity, marked sinus bradycardia, cardiogenic shock, 2nd or 3rd degree AV block (unless pacemaker present)', 
                dosing: {
                    'Adult - VF/Pulseless VT': '300 mg IV bolus, repeat 150 mg.',
                    'Adult - VT with Pulse': '150 mg in 100 mL D5W infused IV over 10 minutes, repeat q10 min PRN.',
                    'Pediatric - VF/Pulseless VT': '5 mg/kg IV bolus (max 300 mg/dose). May repeat twice.',
                    'Pediatric - VT with Pulse': '150 mg in 100 mL D5W infused IV over 60 min.'
                }, 
                route: 'ACP: IV, IO, CVAD, IVAD.' 
            },
            { 
                name: 'Atropine', 
                indications: 'Symptomatic Bradycardia, Antidote for organophosphate poisoning', 
                contraindications: 'Hypersensitivity, narrow-angle glaucoma, myasthenia gravis (no contraindications in life-threatening poisoning)', 
                dosing: {
                    'Adult - Symptomatic Bradycardia': '1 mg IV every 3-5 min (max 3 mg).',
                    'Pediatric - Symptomatic Bradycardia': '0.02 mg/kg IV (max single dose 0.5 mg).',
                    'Adult - Organophosphate Poisoning': '1 to 2 mg; repeat every 5 to 60 minutes as needed. Severe cases: 2 to 6 mg initially.',
                    'Pediatric - Organophosphate Poisoning': '<12 years: 0.05 mg/kg IV initially, then double dose q5 min. ≥12 years: 1 mg IV initially, then double dose q5 min.'
                }, 
                route: 'ACP: IV, IO, ET.' 
            },
            { 
                name: 'Calcium Chloride', 
                indications: 'Treatment of hypocalcemia (e.g., cardiac arrest with hyperkalemia), sine wave pattern ECG, Beta-blocker/Calcium channel blocker overdose', 
                contraindications: 'Hypersensitivity, hypercalcemia, severe renal disease', 
                dosing: {
                    'Cardiac Arrest / Hyperkalemia': '500 to 1000 mg IV over 2 to 5 minutes, may repeat.',
                    'Beta-Blocker / CCB Overdose': 'Contact PADIS. Initial: 1000-2000 mg over 5 min.'
                }, 
                route: 'ACP: IV, IO, CVL.' 
            },
            { 
                name: 'CefTRIAXone', 
                indications: 'Infections (lower respiratory, urinary tract, etc.) with >45 min delay to hospital', 
                contraindications: 'Hypersensitivity to cephalosporins, do not administer with IV calcium-containing solutions', 
                dosing: {
                    'Adult/Elderly': '2 g IV over 5 minutes or infused over 20 minutes.'
                }, 
                route: 'ACP: IV/IO.' 
            },
            { 
                name: 'Dexamethasone', 
                indications: 'Pediatric croup (adjunctive treatment)', 
                contraindications: 'Hypersensitivity, systemic fungal infections, live virus vaccines', 
                dosing: {
                    'Pediatric - Croup': '0.6 mg/kg PO to a max of 16 mg.'
                }, 
                route: 'ACP: PO.' 
            },
            { 
                name: 'Dextrose (D10/D25/D50)', 
                indications: 'Treatment of insulin hypoglycemia', 
                contraindications: 'Hypersensitivity to corn, diabetic coma while hyperglycemic, intracranial hemorrhage', 
                dosing: {
                    'Adult - Hypoglycemia': '12.5 to 25 grams D10W IV over 1 to 5 minutes. Repeat as required.',
                    'Pediatric - Hypoglycemia': '2 to 4 mL/kg D25W IV over 2 to 5 minutes. Repeat as required.',
                    'Neonate - Hypoglycemia': '5 to 10 mL/kg D10W IV over 2 to 5 minutes. Repeat as required.'
                }, 
                route: 'EMR: Oral Glucose; PCP/ICP/ACP: PO/IV/IO.' 
            },
            { 
                name: 'DimenhyDRINATE (Gravol)', 
                indications: 'Nausea, vomiting, vertigo', 
                contraindications: 'Hypersensitivity, concurrent MAOI use, narrow-angle glaucoma, neonates', 
                dosing: {
                    'Adult': '25 to 50 mg IV/IM every 4 hours PRN.',
                    'Elderly': '12.5 mg IV/IM every 4 hours PRN.',
                    'Pediatric (<12 years)': '1 mg/kg (max 50 mg) IV/IM every 4-6 hours PRN.'
                }, 
                route: 'PCP/ICP/ACP: SC/IM/IV.' 
            },
            { 
                name: 'DiphenhydrAMINE (Benadryl)', 
                indications: 'Allergic symptoms, adjunct in anaphylaxis', 
                contraindications: 'Hypersensitivity', 
                dosing: {
                    'Adult/Pediatric': '1 mg/kg IV infusion or IM (max 50 mg). Recommended daily max: 400mg (Adult), 300mg (Peds).'
                }, 
                route: 'ACP: IM/IV.' 
            },
            { 
                name: 'Entonox (Nitrous Oxide)', 
                indications: 'Pain (musculoskeletal, cardiac, burns), active labour', 
                contraindications: 'Head injury with impaired consciousness, inebriation, severe facial injuries, chest trauma (pneumothorax)', 
                dosing: {
                    'All Patients': 'Self-administered via inhalation until pain is relieved.'
                }, 
                route: 'PCP/ICP/ACP: Deep inhalation.' 
            },
            { 
                name: 'EPINEPHrine', 
                indications: 'Anaphylaxis, asthmatic attacks, cardiac arrest, croup, profound bradycardia/hypotension, push dose pressor.', 
                contraindications: 'No absolute contraindications in life-threatening conditions. Hypersensitivity to sulfites.', 
                dosing: {
                    'Adult - Anaphylaxis (Normotensive)': 'IM: 0.5 mg (1:1000) every 5-15 min PRN (max 3 doses).',
                    'Adult - Anaphylaxis (Hypotensive)': 'IV: 100 mcg (10 mL of 1:100,000) over 5-10 min, repeat q5 min PRN.',
                    'Adult - Cardiac Arrest': 'IV/IO Push: 1 mg (1:10,000) every 3-5 min. ETT: 3 mg.',
                    'Adult - Push Dose Pressor': '5-50 mcg (0.5-5 mL of 1:100,000) IVP every 2-5 min.',
                    'Pediatric - Anaphylaxis': 'IM: 0.01 mg/kg (1:1000) (max 0.5 mg/dose), max 3 doses.',
                    'Pediatric - Cardiac Arrest': 'IV/IO Push: 0.01 mg/kg (0.1 mL/kg of 1:10,000) every 3-5 min (max 1 mg/dose). ETT: 0.1 mg/kg (0.1 mL/kg of 1:1000).',
                    'Pediatric - Croup (Nebulized)': '<5 kg: 0.5 mg/kg (1:1000) (max 2.5 mg). >5 kg: 2.5 to 5 mg (1:1000).',
                    'EMR Auto-Injector': 'Adult: 0.3 mg. Peds: 0.15 mg. Repeat in 5 min if needed.'
                }, 
                route: 'IM, IV, IO, Nebulized, ET, Auto-Injector (EMR only).' 
            },
            { 
                name: 'FentaNYL', 
                indications: 'Moderate to severe pain', 
                contraindications: 'Hypersensitivity', 
                dosing: {
                    'Adult - Pain': '0.5 to 2 mcg/kg IV over 1-3 min or IM/IN every 10 min PRN.',
                    'Elderly - Pain': '0.5 to 1 mcg/kg IV/IM/IN, repeat 0.25-0.5 mcg/kg q10 min PRN.',
                    'Pediatric - Pain': '0.5 to 2 mcg/kg IV over 3-5 min or IM q10 min PRN; or 1.5-2 mcg/kg IN.'
                }, 
                route: 'ACP: IV, IO, IN, IM, SC.' 
            },
            { 
                name: 'Glucagon', 
                indications: 'Severe hypoglycemia in patients <4 years or with basal skull fracture without IV access', 
                contraindications: 'Hypersensitivity, Pheochromocytoma', 
                dosing: {
                    'Adult/Peds >12yrs': '1 mg IM/SC. May repeat in 15 min.',
                    'Peds <12yrs': '0.1 mg/kg (max 1mg) IM/SC. May repeat in 15 min.',
                    'Neonate': '0.2 mg/kg (max 1mg) IM/SC.'
                }, 
                route: 'PCP/ICP/ACP: IM/SC/IV.' 
            },
            { 
                name: 'Haloperidol', 
                indications: 'Acute delirium (IM use only)', 
                contraindications: 'Hypersensitivity, severe CNS depression, Parkinson\'s syndrome', 
                dosing: {
                    'Adult (>12 yrs)': '2.5 to 5 mg IM.',
                    'Elderly/Debilitated': '1 to 2.5 mg IM.'
                }, 
                route: 'ACP: IM, SC, IV.' 
            },
            { 
                name: 'HYDROmorphone', 
                indications: 'Pain management and breathlessness in palliative patients already taking it', 
                contraindications: 'Hypersensitivity', 
                dosing: {
                    'Palliative Use Only': 'Dose varies based on patient\'s existing prescription.'
                }, 
                route: 'ACP: PO/Subcut/IV.' 
            },
            { 
                name: 'Ibuprofen', 
                indications: 'Mild to moderate pain, fever (for patients <50 kg)', 
                contraindications: 'Hypersensitivity to NSAIDs, active GI bleeding, 3rd trimester pregnancy', 
                dosing: {
                    'Pediatric (6mo-12yr, <50kg)': '10 mg/kg PO every 6-8 hrs.'
                }, 
                route: 'EMR/PCP/ICP/ACP: PO.' 
            },
            { 
                name: 'Ipratropium', 
                indications: 'Bronchospasm (COPD/Asthma exacerbation)', 
                contraindications: 'Hypersensitivity to ipratropium or atropine', 
                dosing: {
                    'Adult - Nebulized': '250 to 500 mcg.',
                    'Adult - MDI': '5 puffs (20 mcg/puff).',
                    'Pediatric - Nebulized': '125 to 250 mcg.',
                    'Pediatric - MDI (>20kg)': '5 puffs.',
                    'Pediatric - MDI (<20kg)': '4 puffs.'
                }, 
                route: 'PCP/ICP/ACP: Inhalation/Nebulized/ETT.' 
            },
            { 
                name: 'Ketamine', 
                indications: 'Dissociative sedation, secondary for severe pain/agitation, anesthesia', 
                contraindications: 'Conditions where significant BP elevation is hazardous (e.g., uncontrolled hypertension)', 
                dosing: {
                    'Adult/Pediatric - Pain': '0.1 to 0.3 mg/kg IV over >1 min (repeat q10 min) OR 1 mg/kg IN.',
                    'Adult - Severe Agitation': '3 to 4 mg/kg IM.'
                }, 
                route: 'ACP: IM/IN/IV/IO.' 
            },
            { 
                name: 'Ketorolac', 
                indications: 'Short-term management of moderate to severe pain (IM/IV for patients unable to take oral NSAID)', 
                contraindications: 'Hypersensitivity to NSAIDs, active peptic ulcer, renal disease, perioperative pain in CABG', 
                dosing: {
                    'Adult (<65yrs)': '10-15 mg IM/IV over >15s, then q4-6h. Max 120mg/day.',
                    'Adult (>65yrs or <50kg)': '10-15 mg IM/IV over >15s, then lowest effective dose q4-6h. Max 60mg/day.',
                    'Pediatric (2-16yrs)': '0.2-0.5 mg/kg IM/IV over 1-5 min q6-8h. Max 10mg q6h.'
                }, 
                route: 'PCP/ICP/ACP: IM/IV.' 
            },
            { 
                name: 'Lidocaine', 
                indications: 'Cardiac arrest (VF/VT), stable VT, IO pain management', 
                contraindications: 'Hypersensitivity, severe heart block (unless pacemaker present), supraventricular arrhythmias', 
                dosing: {
                    'Adult - VF/Pulseless VT': '1 to 1.5 mg/kg IV Push, repeat 0.5-0.75 mg/kg q5-10 min (max 3 mg/kg).',
                    'Adult - VT with Pulse': '1 to 1.5 mg/kg IV Push, repeat 0.5-0.75 mg/kg until converted (max 3 mg/kg).',
                    'Adult - IO Pain': '0.5 mg/kg IO (max 40 mg).',
                    'Pediatric - VF/Pulseless VT': '1 mg/kg IVP over 2-3 min (max 3 mg/kg).',
                    'Pediatric - IO Pain': '0.5 mg/kg IO (max 20 mg).'
                }, 
                route: 'ACP: IV, IO, Spray, ET.' 
            },
            { 
                name: 'LORazepam', 
                indications: 'Sedation, amnesia, relief of anxiety (SL/PO preferred)', 
                contraindications: 'Hypersensitivity, acute narrow-angle glaucoma, sleep apnea', 
                dosing: {
                    'Adult/Peds >12yrs (<50kg)': '1 mg SL/PO, repeat q4-6h PRN (max 10mg/day).',
                    'Adult/Peds >12yrs (>50kg)': '1 to 2 mg SL/PO, repeat q4-6h PRN (max 10mg/day).'
                }, 
                route: 'ICP (Med Control)/ACP: SL/PO/IM/SubQ/IV.' 
            },
            { 
                name: 'Magnesium Sulfate', 
                indications: 'Torsades de pointes, eclampsia, severe bronchospasm', 
                contraindications: 'Hypersensitivity, heart block, myocardial damage', 
                dosing: {
                    'Eclampsia': '4 g IV in 100mL NS over 20 min.',
                    'Torsades (Arrest)': '1 to 2 g IVP diluted in 10mL NS.',
                    'Torsades (Pulse)': '1 to 2 g IV in 50mL NS over 15 min.',
                    'Asthma (Adult)': '1 to 2 g IV over 20-30 min.',
                    'Asthma (Peds)': '25 to 75 mg/kg (max 2g) IV over 20 min.'
                }, 
                route: 'ACP: IV/IO.' 
            },
            { 
                name: 'MethylPREDNISolone', 
                indications: 'Adjunctive for anaphylaxis, bronchospasm (Asthma/COPD), adult croup', 
                contraindications: 'Hypersensitivity, active tuberculosis, systemic fungal infections', 
                dosing: {
                    'Adult': '1 mg/kg IV (max 125 mg) over >2-3 min or infused over 20 min.',
                    'Pediatric': '1 mg/kg/dose every 6 hrs (max 60 mg/24h).'
                }, 
                route: 'ACP: IM/IV/IO.' 
            },
            { 
                name: 'Midazolam', 
                indications: 'Sedation, seizure control, severe agitation', 
                contraindications: 'Hypersensitivity, acute pulmonary insufficiency, narrow-angle glaucoma', 
                dosing: {
                    'Adult - Seizure': '10 mg IM/IN or 2.5 mg IV q2 min (max 10mg).',
                    'Adult - Agitation': '2.5-5 mg IM/IV q3-10 min (max 20mg).',
                    'Pediatric - Seizure': '0.2 mg/kg IM/IN or 0.1 mg/kg IV q10 min (max 10mg).'
                }, 
                route: 'ICP (Seizure)/ACP: IM/IV/IO/IN.' 
            },
            { 
                name: 'Morphine', 
                indications: 'Severe acute or chronic pain', 
                contraindications: 'Hypersensitivity', 
                dosing: {
                    'Adult/Peds': '0.05 to 0.1 mg/kg IV/IM/IN, repeat 0.025-0.05 mg/kg q15 min PRN.',
                    'Elderly': '0.025 to 0.05 mg/kg IV/IM/IN, repeat 0.01 mg/kg q15 min PRN.'
                }, 
                route: 'ACP: IM/IV/IO/SQ.' 
            },
            { 
                name: 'Naloxone', 
                indications: 'Reversal of narcotic depression, suspected opioid overdose', 
                contraindications: 'Hypersensitivity', 
                dosing: {
                    'Adult/Elderly': '0.5 to 1.0 mg IM/IV/IN every 2-3 min, titrate to adequate ventilations.',
                    'Pediatric/Neonate': '0.1 mg/kg/dose IM/IV/IN every 2-3 min, titrate. Do not give to neonates in resuscitation immediately post-delivery.'
                }, 
                route: 'EMR/PCP/ICP/ACP: IM/IV/IN/SQ.' 
            },
            { 
                name: 'Naproxen', 
                indications: 'Musculoskeletal trauma, burns, pain management', 
                contraindications: 'Hypersensitivity to NSAIDs, pregnancy, active GI bleeding', 
                dosing: {
                    'Adult/Elderly': '250-500 mg PO, then 250-500 mg q12h or 250mg q6-8h PRN.',
                    'Peds >50kg': '250 mg PO q8-12h.'
                }, 
                route: 'EMR/PCP/ICP/ACP: PO.' 
            },
            { 
                name: 'NitroGLYCERIN', 
                indications: 'Chest pain of cardiac origin, acute pulmonary edema', 
                contraindications: 'Hypersensitivity, hypotension, increased ICP, use of phosphodiesterase-5 inhibitors', 
                dosing: {
                    'Chest Pain': '0.4 mg SL every 3-5 min (max 3 sprays).',
                    'Pulmonary Edema (SL)': '0.4 mg SL every 3-5 min until SBP < 140mmHg.',
                    'Pulmonary Edema (IV)': 'Start 20 mcg/min, titrate by 10 mcg/min q5 min PRN (max 200 mcg/min).'
                }, 
                route: 'EMR (Assist)/PCP/ICP/ACP: SL/IV.' 
            },
            { 
                name: 'Norepinephrine', 
                indications: 'Acute hypotension or shock states', 
                contraindications: 'Hypersensitivity, suspected mesenteric infarction', 
                dosing: {
                    'Adult - IV Infusion': 'Start 0.1 mcg/kg/min, titrate by 0.05 mcg/kg/min to desired BP.'
                }, 
                route: 'ACP: IV/IO.' 
            },
            { 
                name: 'Ondansetron', 
                indications: 'Prevention of nausea and vomiting', 
                contraindications: 'Hypersensitivity', 
                dosing: {
                    'Adult (<65yrs)': '4 mg IV/IM/PO/Buccal q6h.',
                    'Elderly (>65yrs)': '4 mg IV infusion/IM/PO/Buccal q6h.',
                    'Peds (<5yrs)': '2 mg IV/IM q6h.',
                    'Peds (>5yrs)': '4 mg IV/IM/Buccal q6h.'
                }, 
                route: 'PCP/ICP/ACP: IM/IV/PO/Buccal.' 
            },
            { 
                name: 'Oxytocin', 
                indications: 'Control of postpartum hemorrhage', 
                contraindications: 'Hypersensitivity, major cephalopelvic disproportion, fetal malpresentation', 
                dosing: {
                    'Post-Birth (Prophylaxis)': '10 units IM at delivery of anterior shoulder.',
                    'Postpartum Hemorrhage (PPH)': '10 units IM or 30 units in 500mL IV infusion.'
                }, 
                route: 'PCP/ICP/ACP: IM/IV/IO.' 
            },
            { 
                name: 'Salbutamol (Ventolin)', 
                indications: 'Severe bronchospasm, hyperkalemia', 
                contraindications: 'Hypersensitivity, tachyarrhythmias', 
                dosing: {
                    'Adult - Nebulized': '2.5 to 5.0 mg, may repeat PRN.',
                    'Adult - MDI': '10 puffs (100mcg/puff).',
                    'Hyperkalemia': '10 to 20 mg via nebulizer over 10 min.',
                    'Pediatric - Nebulized': '1.25 to 2.5 mg, may repeat PRN.',
                    'Pediatric - MDI (>20kg)': '10 puffs.',
                    'Pediatric - MDI (<20kg)': '5 puffs.'
                }, 
                route: 'PCP/ICP/ACP: Nebulized/MDI/ETT.' 
            },
            { 
                name: 'Sodium Bicarbonate', 
                indications: 'Known TCA overdose or hyperkalemia with QRS widening, hyperkalemic cardiac arrest', 
                contraindications: 'Metabolic or respiratory alkalosis, hypocalcemia', 
                dosing: {
                    'Hyperkalemic Cardiac Arrest': '1 mEq/kg IVP.',
                    'TCA / Sodium Channel Blocker OD': 'Contact PADIS. 1-2 mEq/kg IV over 1-2 min, repeat q10 min until QRS narrows.'
                }, 
                route: 'ACP: IV/IO.' 
            },
            { 
                name: 'Thiamine', 
                indications: 'Hypoglycemic patients who received D50W and appear malnourished', 
                contraindications: 'Hypersensitivity', 
                dosing: {
                    'Adult': '100 mg IV push over 1 minute.'
                }, 
                route: 'ACP: IM/IV/IO.' 
            },
            { 
                name: 'Tranexamic Acid (TXA)', 
                indications: 'Trauma-associated hemorrhage, postpartum hemorrhage', 
                contraindications: 'Hypersensitivity, active intravascular clotting, subarachnoid hemorrhage', 
                dosing: {
                    'Trauma / PPH': '2 g in 100 mL NS infused IV over 20 minutes.'
                }, 
                route: 'ACP: IV/IO.' 
            },
        ];

        // --- DOM ELEMENTS & FUNCTIONS ---
        const medicationListContainer = document.getElementById('medicationList');
        const searchInput = document.getElementById('searchInput');
        const noResultsContainer = document.getElementById('noResults');
        const azNavContainer = document.getElementById('az-nav');
        
        function renderMedications(filter = '') {
            medicationListContainer.innerHTML = '';
            const searchTerm = filter.toLowerCase().trim();
            const filteredMeds = medications.filter(med => 
                Object.values(med).some(value => {
                    if (typeof value === 'object' && value !== null) {
                        return Object.entries(value).some(([key, val]) => 
                            key.toLowerCase().includes(searchTerm) || val.toLowerCase().includes(searchTerm)
                        );
                    }
                    return String(value).toLowerCase().includes(searchTerm);
                })
            );
            if (filteredMeds.length === 0) {
                noResultsContainer.classList.remove('hidden');
            } else {
                noResultsContainer.classList.add('hidden');
                const groupedMeds = filteredMeds.reduce((acc, med) => {
                    const firstLetter = med.name.charAt(0).toUpperCase();
                    if (!acc[firstLetter]) acc[firstLetter] = [];
                    acc[firstLetter].push(med);
                    return acc;
                }, {});
                Object.keys(groupedMeds).sort().forEach(letter => {
                    const heading = document.createElement('div');
                    heading.id = `letter-${letter}`;
                    heading.className = 'pt-2';
                    heading.innerHTML = `<h2 class="text-2xl font-bold text-teal-700 border-b-2 border-teal-200 pb-2">${letter}</h2>`;
                    medicationListContainer.appendChild(heading);
                    groupedMeds[letter].forEach(med => {
                        const card = createMedicationCard(med);
                        medicationListContainer.appendChild(card);
                    });
                });
            }
        }

        function createMedicationCard(med) {
            const div = document.createElement('div');
            div.className = 'bg-white rounded-xl shadow-sm overflow-hidden transition-shadow duration-300 hover:shadow-lg';
            div.innerHTML = `
                <div class="accordion-header p-5 cursor-pointer flex justify-between items-center hover:bg-slate-50/50">
                    <h3 class="text-lg font-semibold text-slate-900">${med.name}</h3>
                    <svg class="w-6 h-6 text-slate-500" fill="none" stroke="currentColor" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
                </div>
                <div class="accordion-content border-t border-slate-200">
                    <div class="px-5 sm:px-6 py-2 grid grid-cols-1 gap-y-6">
                        <div class="flex items-start gap-4">
                            <div class="flex-shrink-0 w-8 h-8 rounded-full bg-teal-50 flex items-center justify-center">
                                <svg class="w-5 h-5 text-teal-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor"><path stroke-linecap="round" stroke-linejoin="round" d="M9 12.75 11.25 15 15 9.75M21 12a9 9 0 1 1-18 0 9 9 0 0 1 18 0Z" /></svg>
                            </div>
                            <div>
                                <h4 class="text-sm font-bold text-teal-700 uppercase tracking-wider">Indications</h4>
                                <p class="mt-1 text-slate-700 leading-relaxed">${med.indications}</p>
                            </div>
                        </div>
                        <div class="flex items-start gap-4">
                            <div class="flex-shrink-0 w-8 h-8 rounded-full bg-red-50 flex items-center justify-center">
                                <svg class="w-5 h-5 text-red-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor"><path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126ZM12 15.75h.007v.008H12v-.008Z" /></svg>
                            </div>
                            <div>
                                <h4 class="text-sm font-bold text-red-700 uppercase tracking-wider">Contraindications</h4>
                                <p class="mt-1 text-slate-700 leading-relaxed">${med.contraindications}</p>
                            </div>
                        </div>
                        <div class="flex items-start gap-4">
                            <div class="flex-shrink-0 w-8 h-8 rounded-full bg-sky-50 flex items-center justify-center">
                                <svg class="w-5 h-5 text-sky-600" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor"><path stroke-linecap="round" stroke-linejoin="round" d="M12 6v6h4.5m4.5 0a9 9 0 1 1-18 0 9 9 0 0 1 18 0Z" /></svg>
                            </div>
                            <div>
                                <h4 class="text-sm font-bold text-sky-700 uppercase tracking-wider">Dosing & Route</h4>
                                <div class="dosing-details mt-2 space-y-3"></div>
                                <p class="mt-3 text-slate-700 leading-relaxed"><strong>Route:</strong> ${med.route}</p>
                            </div>
                        </div>
                    </div>
                </div>
            `;
            const dosingContainer = div.querySelector('.dosing-details');
            for (const [indication, dose] of Object.entries(med.dosing)) {
                const doseElement = document.createElement('div');
                doseElement.innerHTML = `<p class="text-sm text-slate-700 leading-relaxed"><strong class="font-semibold text-slate-900 block">${indication}:</strong><span>${dose}</span></p>`;
                dosingContainer.appendChild(doseElement);
            }
            return div;
        }

        function generateAzNav() {
            const alphabet = 'ABCDEFGHIJKLMNOPQRSTUVWXYZ'.split('');
            alphabet.forEach(letter => {
                const link = document.createElement('a');
                link.href = `#letter-${letter}`;
                link.textContent = letter;
                link.className = 'px-2.5 py-1.5 rounded-md text-slate-600 hover:bg-teal-100 hover:text-teal-800 transition-colors duration-200';
                azNavContainer.appendChild(link);
            });
        }

        // --- EVENT LISTENERS ---
        searchInput.addEventListener('input', (e) => {
            renderMedications(e.target.value);
        });
        medicationListContainer.addEventListener('click', (e) => {
            const header = e.target.closest('.accordion-header');
            if (header) {
                const content = header.nextElementSibling;
                header.classList.toggle('open');
                content.classList.toggle('open');
            }
        });
        azNavContainer.addEventListener('click', (e) => {
            if (e.target.tagName === 'A') {
                e.preventDefault();
                const targetId = e.target.getAttribute('href');
                const targetElement = document.querySelector(targetId);
                if (targetElement) {
                    targetElement.scrollIntoView({
                        behavior: 'smooth',
                        block: 'start'
                    });
                }
            }
        });
        document.addEventListener('DOMContentLoaded', () => {
            renderMedications();
            generateAzNav();
        });
    </script>
</body>
</html>


